1 April 2020 price disclosure confirmed prices

31 March 2020 - Confirmed 1 April 2020 prices resulting from the 2020 April cycle of price disclosure have been published ...

Read more →

Standardised redactions to Public Summary Documents – nominations open for participation in the final trial, and implementation from July 2020

5 March 2020 - The Department is now seeking nominations from sponsors with submissions due to be considered at the ...

Read more →

FDA launches new Purple Book searchable database to help patients and prescribers identify FDA-approved biologic and biosimilar treatment options

24 February 2020 - Today, the FDA is releasing the first phase of the enhancement of the “Purple Book: Database of ...

Read more →

2020 April price disclosure cycle - indicative prices

3 February 2020 - Indicative 1 April 2020 prices resulting from the 2020 April Cycle of Price Disclosure have now been ...

Read more →

Documents disclosed to the EMA as part of an MA application process are not presumed to be confidential

28 January 2020 - On 22 January 2020 the CJEU handed down two decisions in which it decided that the ...

Read more →

Court of Justice upholds EMA’s approach to transparency

22 January 2020 - EMA welcomes today’s two appellate judgments by the Court of Justice that confirmed, in clear and ...

Read more →

Talkin’ about a resolution: issues in the push for greater transparency of medicine prices

20 January 2020 - At the 2019 World Health Assembly, a significant new resolution was agreed by most countries to start ...

Read more →

Defending transparency at European drug regulator

8 January 2020 - Forthcoming judgment must uphold public access to clinical data ...

Read more →

Price disclosure 2020 April cycle outcomes summary

18 December 2019 - The summary of price disclosure price reductions for the 2020 April Cycle has now been published. ...

Read more →

Hospital groups sue to block price transparency rule

4 December 2019 - Health care providers say disclosure requirement pushed by Trump violates First Amendment. ...

Read more →

How to navigate specialist fees in the private health system

26 November 2019 - Have you ever taken up private health insurance, only to end up hundreds or thousands of ...

Read more →

Transparency is a first step in bringing down drug costs for American seniors, families

21 November 2019 - Wherever I go — be it to school events, county fairs, town halls, or even the ...

Read more →

To lower costs, Trump to force hospitals to reveal price of care

15 November 2019 - The Trump administration on Friday announced it would begin forcing hospitals to publicly disclose the discounted ...

Read more →

Improving transparency in decision models: current issues and potential solutions

23 October 2019 - Decision-analytic models have become an essential tool used to inform health technology assessments. ...

Read more →

NICE, in confidence: an assessment of redaction to obscure confidential information in single technology appraisals by the National Institute for Health and Care Excellence

17 November 2019 - Health technology assessment aims to provide a transparent framework within which normative judgements can be applied for ...

Read more →